Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:02:31.942Z.
Calculation as of: 2026-10-06T16:02:31.942Z.
Quote observation: 2026-10-06T16:00:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f97479f440d7a03605f533a56e26179237db48e588053495707f458dff3bcd44
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$5.09B
Operating Cash Flow Yield
5.57%
TTM Avg
6.10%
3Y Avg
4.38%
5Y Avg
3.97%
Market Cap
$5.18B
Operating Cash Flow Yield
N/A
TTM Avg
4.29%
3Y Avg
4.29%
5Y Avg
4.29%
Market Cap
$5.22B
Operating Cash Flow Yield
N/A
TTM Avg
9.45%
3Y Avg
5.30%
5Y Avg
5.30%
Market Cap
$5.24B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.90B
Operating Cash Flow Yield
N/A
TTM Avg
0.78%
3Y Avg
0.73%
5Y Avg
0.73%
Market Cap
$4.86B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.86B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.36B
Operating Cash Flow Yield
5.72%
TTM Avg
5.66%
3Y Avg
3.61%
5Y Avg
2.96%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $5.08B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.09B | 5.57% | 6.10% | 4.38% | 3.97% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.18B | N/A | 4.29% | 4.29% | 4.29% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | N/A | 9.45% | 5.30% | 5.30% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.24B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.90B | N/A | 0.78% | 0.73% | 0.73% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.86B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.86B | N/A | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.36B | 5.72% | 5.66% | 3.61% | 2.96% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.38B | N/A | 13.90% | 13.90% | 13.90% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
